Eteplirsen Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/mL
Reference Brands: Exondys 51 (USA/EU)
Category: Neurology
Eteplirsen is an antisense oligonucleotide used to treat Duchenne Muscular Dystrophy (DMD) in patients with a confirmed mutation amenable to exon 51 skipping. It works by promoting the production of functional dystrophin protein, which is crucial for maintaining muscle strength and function. Eteplirsen is administered as an intravenous infusion, typically once a week. Eteplirsen is available in Injection and strengths such as 50 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Eteplirsen is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Eteplirsen can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Eteplirsen is used to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping.
Eteplirsen is made from a synthetic phosphorodiamidate morpholino oligomer (PMO) that binds to specific RNA sequences to promote exon 51 skipping during dystrophin protein synthesis.
The trade name of Eteplirsen is Exondys 51.
Eteplirsen is made by Sarepta Therapeutics, Inc.
The generic name of the product is Eteplirsen.
The brand name of Eteplirsen is Exondys 51.
Eteplirsen is manufactured by Sarepta Therapeutics, Inc. in the United States.
Related Products
Memantine
Strength:
5 mg, 10 mg, 10 mg/5 ml
Form: Tablets / Oral solution
Reference Brands: Namenda (USA), Ebixa (EU/UK)
View Details
Sodium Oxybate
Strength:
500 mg/ml
Form: Oral Solution
Reference Brands: Xyrem (USA/EU), Lumryz (USA/EU)
View Details
Quick Response Guaranteed | Verified Suppliers
